• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Mersana Therapeutics Inc (NQ: MRSN )

    2.550 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Mersana Therapeutics Inc

    < Previous 1 2 3 4 5 Next >
    Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
    Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. 
    Via Benzinga
    Mersana, GSK Ink $1.36B Biobuck Deal For Cancer-Focused Therapy
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
      
    Via Benzinga
    Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
    Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.... 
    Via Benzinga
    Recap: Mersana Therapeutics Q1 Earnings
    Mersana Therapeutics (NASDAQ:MRSN) reported its Q1 earnings results on Monday, May 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Why U.S. Stocks Are Trading Mixed; Labor Costs Increase Higher-Than-Expected In Q2
    U.S. stocks traded mixed this morning, with the Nasdaq dropping around 90 points on Tuesday. 
    Via Benzinga
    Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
      
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
      
    Via Benzinga
    Earnings Scheduled For February 28, 2022
    Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (... 
    Via Benzinga
    Earnings Scheduled For August 8, 2022
    Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter. 
    Via Benzinga
    Earnings Preview For Mersana Therapeutics
    Mersana Therapeutics (NASDAQ:MRSN) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement. Analysts estimate that Mersana... 
    Via Benzinga
    89 Biggest Movers From Friday
    Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy. 
    Via Benzinga
    Mersana Therapeutics's Return On Capital Employed Overview
    According to Benzinga Pro data, during Q1, Mersana Therapeutics (NASDAQ:MRSN) posted sales of $2.04 million. Earnings were up 3.52%, but Mersana Therapeutics still reported an overall loss of $47.26... 
    Via Benzinga
    Executives Buy Around $17M Of 5 Penny Stocks
    The Nasdaq Composite index tumbled by more than 550 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their... 
    Via Benzinga
    Mersana Stock Gains On FDA Orphan Drug Designation For Gastric Cancer Drug
    Mersana Therapeutics, Inc. (NASDAQ: MRSN) received orphan drug designation from the U.S. Food and Drug Administration (FDA) for its drug candidate XMT-2056 or the treatment of gastric cancer. The... 
    Via Benzinga
    The Daily Biotech Pulse: Valneva's COVID-19 Vaccine Filing Accepted By EMA, Enanta's RSV Candidate Fails, Orphan Drug Tag For Mersana's Gastric Cancer Candidate
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    34 Stocks Moving In Monday's Mid-Day Session
    Gainers Casa Systems, Inc. (NASDAQ: CASA) shares climbed 66.3% to $6.47 after the company announced a multi-year contract with Verizon to provide 5G core network functions.... 
    Via Benzinga
    Earnings Scheduled For May 9, 2022
    Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million. 
    Via Benzinga
    68 Biggest Movers From Yesterday
    Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core... 
    Via Benzinga
    The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Gainers Creative Medical Tech (NASDAQ:CELZ) shares rose 78.8% to $3.04 during Wednesday's pre-market session. The market value of their outstanding shares is at $19.2... 
    Via Benzinga
    Looking Into Mersana Therapeutics's Return On Capital Employed
    Mersana Therapeutics (NASDAQ:MRSN) brought in sales totaling $11.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 7.72%, resulting in... 
    Via Benzinga
    Recap: Mersana Therapeutics Q4 Earnings
    Mersana Therapeutics (NASDAQ:MRSN) reported its Q4 earnings results on Monday, February 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Gainers Avenue Therapeutics (NASDAQ:ATXI... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Gainers Avenue Therapeutics (NASDAQ:ATXI)... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    On Wednesday, 115 companies reached new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low... 
    Via Benzinga
    78 Biggest Movers From Friday
    Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education... 
    Via Benzinga
    60 Biggest Movers From Yesterday
    Gainers US Ecology, Inc. (NASDAQ: ECOL) shares surged 67.7% to close at $47.25 on Wednesday after Republic Services reported it will buy the company at $48 per share in cash.... 
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.